April 25 (Reuters) - Merck KGaA MRCG.DE:
EQS-ADHOC: MERCK KGAA: MERCK CONFIRMS LATE-STAGE DISCUSSIONS WITH SPRINGWORKS THERAPEUTICS, INC. ON POTENTIAL ACQUISITION
MERCK KGAA: PARTIES ARE IN DISCUSSION ON BASIS OF A PRICE OF AROUND USD 47 PER SHARE
MERCK KGAA: NO FINAL DECISION HAS BEEN TAKEN AND NO LEGALLY BINDING AGREEMENT HAS BEEN ENTERED INTO
Source text: ID:nEQ3NsrHga
Further company coverage: MRCG.DE
((reuters.briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。